Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CVS Group
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Rising Pet Ownership And Digital Integration Will Transform Veterinary Care
Key Takeaways Accelerating synergy benefits and digital enhancements are driving faster-than-expected margin expansion and creating underappreciated opportunities for recurring revenue growth. Favourable industry trends and a strong clinical reputation position the company for sustained growth, enhanced pricing power, and strategic consolidation opportunities.
View narrative
UK£19.65
FV
38.2% undervalued
intrinsic discount
6.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Coinbase Global
AN
AnalystConsensusTarget
Consensus Narrative from 29 Analysts
Blockchain Tokenization Will Expand Markets Though Cybersecurity Risks Persist
Key Takeaways Growing institutional partnerships and expanded blockchain product offerings position Coinbase as the leading access point for digital asset adoption and advanced trading activity. Proprietary blockchain platforms and integrated payment solutions enable ecosystem lock-in and drive a shift toward higher-margin services and recurring revenue streams.
View narrative
US$365.88
FV
15.1% undervalued
intrinsic discount
8.25%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
1
users have commented on this narrative
187
users have followed this narrative
4 days ago
author updated this narrative
Jindal Saw
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Urbanization And Clean Energy Will Drive Advanced Pipe Demand
Key Takeaways Jindal Saw is set for faster-than-expected topline and margin growth due to pent-up demand, premium products, and strategic international expansion. Industry consolidation, robust balance sheet, and expansion into high-spec pipe markets uniquely position the company for rapid market share gains and sustained profit growth.
View narrative
₹452.00
FV
54.3% undervalued
intrinsic discount
10.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Grupo México. de
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Global Electrification And Urbanization Will Fuel Copper Demand
Key Takeaways Upcoming projects in Peru and ongoing cost reductions position the company for industry-leading margin expansion amid a supportive global copper environment. Robust balance sheet and strategic focus on core investments, including ESG leadership and transportation, support sustained growth, resilience, and institutional investor appeal.
View narrative
Mex$167.81
FV
26.5% undervalued
intrinsic discount
6.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Burjeel Holdings
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Rising Health Awareness And Telemedicine Will Expand MENA Healthcare
Key Takeaways Rapid expansion in high-growth specialties and mental health is unlocking new high-margin revenue streams and driving faster-than-expected profit growth. Asset-light international partnerships and advanced healthcare technology investments are structurally improving efficiency, patient volumes, and long-term profitability.
View narrative
د.إ2.88
FV
47.6% undervalued
intrinsic discount
10.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Welspun
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global Infrastructure Trends And Clean Energy Will Boost Pipe Demand
Key Takeaways Welspun is positioned for sustained revenue and margin growth through global market share gains, premium products, and strategic capacity additions supported by favorable policy trends. Expansion into specialty segments and polymer pipes, along with operational improvements, could drive significant cash flow increases and make current valuations seem undervalued.
View narrative
₹1.19k
FV
26.9% undervalued
intrinsic discount
26.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Quanta Services
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Transmission And Renewables Investments Will Strengthen Energy Resilience
Key Takeaways Robust demand for grid modernization, renewables, and data center power drives long-term growth, with expanding project pipelines and high-value contracts improving earnings stability. Strategic acquisitions, service diversification, and execution expertise enhance Quanta's competitive edge, enabling margin expansion and resilience amid industry complexity and labor shortages.
View narrative
US$418.17
FV
7.7% undervalued
intrinsic discount
12.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
31
users have followed this narrative
Updated
narrative
Agios Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Precision Therapies Will Serve Aging Populations While Facing Regulatory Delays
Key Takeaways Accelerated global expansion and rapid market adoption are fueled by strong partnerships, clear patient targeting, and proactive payer and clinician engagement. Multiple near-term clinical advancements and pipeline synergies position Agios for transformative revenue growth and margin improvement, surpassing standard industry progress.
View narrative
US$65.00
FV
45.0% undervalued
intrinsic discount
121.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
PostNL
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Digitalization And E-Commerce Will Enable Sustainable Parcel Advances
Key Takeaways Expansion of parcel lockers, digitalization, and automation are expected to significantly enhance margins and earnings resilience by reducing costs and supporting scale. Strong ESG credentials and a shift to an asset-light, cross-border delivery model boost revenue growth prospects and set PostNL apart from slower competitors.
View narrative
€1.20
FV
19.8% undervalued
intrinsic discount
2.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies